drugset

drugset / Trial / NCT01367249

Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

NCT01367249 ↗

Phase 3 Completed 440 enrolled Bausch & Lomb Incorporated

RandomizedParallel-groupDouble-blindTreatment

Summary

This is an efficacy study of Bromfenac Ophthalmic Solution in cataract surgery.

Timeline

Start: 2011-05
Primary completion: 2011-07
Completion: 2011-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bromfenac	Other / unclassified	0.07 %	Other

Indications